Children's cough syrup recalled over bacteria concerns
(WKBN) – The presence of a bacterium that can cause two types of foodborne illnesses has prompted the recall of multiple lots of a children's cough syrup, a notice posted to the Food and Drug Administration's website announced this week.
Medtech Products Inc. is recalling five lots of Little Remedies Honey Cough Syrup due to the presence of Bacillus cereus, as well as the 'loss of shelf-stability,' the company explained.
The recalled products were distributed nationwide. They were sold 4-ounce bottles, both in stores and online, between Dec. 14, 2022, and June 4, 2025.
Identifying information, including the UPC and lot numbers, as well as the expiration dates, can be found below:
No other Little Remedies products were included in the recall.
While no serious adverse events have been reported in connection to the cough syrup, the FDA warns that Bacillus cereus can cause short-term illness and, in some cases, lead to death.
Bacillus cereus, or B. cereus, is a spore-forming bacterium that commonly exists in our environment, the Cleveland Clinic explains. Exposure to the toxin it creates can result in one of two types of illness — one described as a diarrheal syndrome and another as a vomiting syndrome. The first is characterized by cramps and watery diarrhea, while the second more commonly causes nausea and vomiting.
In severe cases, Bacillus cereus infection can lead to death.
Those who believe they may be suffering from an illness caused by Bacillus cereus are urged to contact a healthcare provider.
Customers who purchased the recalled Little Remedies cough syrup are being told to discard the product. Those with questions or refund requests can reach Medtech at 1-800-754-8853, by email at medicalaffairs@prestigebrands.com, or through the company's website.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Chicago Tribune
an hour ago
- Chicago Tribune
FDA requires updated warning about rare heart risk with COVID shots
WASHINGTON — The Food and Drug Administration said Wednesday it has expanded existing warnings on the two leading COVID-19 vaccines about a rare heart side effect mainly seen in young men. Myocarditis, a type of heart inflammation that is usually mild, emerged as a complication after the first shots became widely available in 2021. Prescribing information from both Pfizer and Moderna already advises doctors about the issue. In April, the FDA sent letters to both drugmakers asking them to update and expand the warnings to add more detail about the problem and to cover a larger group of patients. While the FDA can mandate label changes, the process is often more of a negotiation with companies. Specifically, the new warning lists the risk of myocarditis as 8 cases per 1 million people who got the 2023-2024 COVID shots between the ages of 6 months and 64 years old. The label also notes that the problem has been most common among males ages 12 to 24. The previous label said the problem mostly occurs in 12- to 17-year-olds. The FDA's labeling change appears to conflict with some prior findings of scientists elsewhere in the U.S. government. The Centers for Disease Control and Prevention previously concluded there was no increased risk of myocarditis detected in government vaccine injury databases for COVID-19 shots dating back to 2022. Officials also noted that cases tend to resolve quickly and are less severe than those associated with COVID-19 infection itself, which can also cause myocarditis. The FDA announcement came as new vaccine advisers appointed by Health Secretary Robert F. Kennedy Jr. met to debate the continuing use of COVID-19 vaccines for key groups, including pregnant women. It's the first meeting of the CDC advisory panel since Kennedy abruptly dismissed all 17 members of the group, naming a new panel that includes several members with a history of anti-vaccine statements. The FDA's label update is the latest step by officials working under Kennedy to restrict or undercut use of vaccines. FDA Commissioner Marty Makary and a top deputy recently restricted annual COVID-19 shots to seniors and other Americans at higher risk from the virus. They've also suggested seasonal tweaks to match the latest circulating virus strains are new products that require extra testing. Outside experts said the new warning is the wrong approach. 'They are right to suggest that we need to consider myocarditis risks associated with the vaccine, but what they propose is exactly the wrong solution,' said Dr. Robert Morris, a public health specialist at the University of Washington. 'We should be investigating who is prone to myocarditis to see if we can predict and mitigate that risk.' Makary and several other FDA officials gained prominence during the pandemic by suggesting the federal government exaggerated the benefits of COVID-19 boosters and downplayed serious side effects, including myocarditis. Before joining the government, Makary and two of his current FDA deputies wrote a 2022 paper that said mandating booster shots in young people would cause more vaccine-related injuries than prevented hospitalizations from COVID-19 infections. The conclusion contradicted that of many leading vaccine and public health experts at the time, including at the CDC.
Miami Herald
2 hours ago
- Miami Herald
Bacteria that can cause vomiting, diarrhea gets kids' cough syrup recalled
Parents, guardians and all who care for kids should check their medicine cabinets after a children's cough syrup was recalled for a foodborne bacteria that can cause myriad problems. And, in extreme cases, cause death. Medtech Products' recall notice, posted to the FDA website, said it recalled five lots of Little Remedies Honey Cough Syrup for the 'presence of Bacillus cereus and loss of shelf-stability.' That bacteria can bring on two kinds of foodborne illnesses. 'One type is characterized by nausea, vomiting, and stomach cramps that can start one to six hours after eating or drinking contaminated food,' Medtech's notice said. 'The second type can cause stomach cramps and diarrhea that can start eight to 16 hours after eating or drinking contaminated food. 'Although healthy individuals may suffer only short-term illness, exposure to high levels of foodborne B. cereus can cause death.' Recalled lot Nos. are 0039, expiration date 11/2025; 0545, expiration date 1/2026; 0640, expiration date 2/2026; 0450, expiration date 5/2026; and 1198, expiration date 12/2026. For refunds, Medtech is asking customers to go to the Prestige Brands website, email medicalaffairs@ or call 800-754-8853, Monday through Friday, 8:30 a.m. to 5:30 p.m., Eastern time. Any medical problems should be taken to a medical professional first. Then notify the FDA's MedWatch program by filling out a report online. After that, tell Medtech.
2 hours ago
FDA requires updated warning about rare heart risk with COVID shots
WASHINGTON -- WASHINGTON (AP) — The Food and Drug Administration said Wednesday it has expanded existing warnings on the two leading COVID-19 vaccines about a rare heart side effect mainly seen in young men. Myocarditis, a type of heart inflammation that is usually mild, emerged as a complication after the first shots became widely available in 2021. Prescribing information from both Pfizer and Moderna already advises doctors about the issue. In April, the FDA sent letters to both drugmakers asking them to update and expand the warnings to add more detail about the problem and to cover a larger group of patients. While the FDA can mandate label changes, the process is often more of a negotiation with companies. Specifically, the new warning lists the risk of myocarditis as 8 cases per 1 million people who got the 2023-2024 COVID shots between the ages of 6 months and 64 years old. The label also notes that the problem has been most common among males ages 12 to 24. The previous label said the problem mostly occurs in 12- to 17-year-olds. The FDA's labeling change appears to conflict with some prior findings of scientists elsewhere in the U.S. government. The Centers for Disease Control and Prevention previously concluded there was no increased risk of myocarditis detected in government vaccine injury databases for COVID-19 shots dating back to 2022. Officials also noted that cases tend to resolve quickly and are less severe than those associated with COVID-19 infection itself, which can also cause myocarditis. The FDA announcement came as new vaccine advisers appointed by Health Secretary Robert F. Kennedy Jr. met to debate the continuing use of COVID-19 vaccines for key groups, including pregnant women. It's the first meeting of the CDC advisory panel since Kennedy abruptly dismissed all 17 members of the group, naming a new panel that includes several members with a history of anti-vaccine statements. The FDA's label update is the latest step by officials working under Kennedy to restrict or undercut use of vaccines. FDA Commissioner Marty Makary and a top deputy recently restricted annual COVID-19 shots to seniors and other Americans at higher risk from the virus. They've also suggested seasonal tweaks to match the latest circulating virus strains are new products that require extra testing. Outside experts said the new warning is the wrong approach. 'They are right to suggest that we need to consider myocarditis risks associated with the vaccine, but what they propose is exactly the wrong solution,' said Dr. Robert Morris, a public health specialist at the University of Washington. 'We should be investigating who is prone to myocarditis to see if we can predict and mitigate that risk.' Makary and several other FDA officials gained prominence during the pandemic by suggesting the federal government exaggerated the benefits of COVID-19 boosters and downplayed serious side effects, including myocarditis. Before joining the government, Makary and two of his current FDA deputies wrote a 2022 paper that said mandating booster shots in young people would cause more vaccine-related injuries than prevented hospitalizations from COVID-19 infections. The conclusion contradicted that of many leading vaccine and public health experts at the time, including at the CDC. ___
